Press

CURE Pharmaceutical to Present at H.C. Wainwright 2021 Psychedelics in Psychiatry and Beyond Virtual Conference

Jun 15 • 2 min read

Quick Take: CURE Pharmaceutical’s chief business officer Jonathen Berlent will be speaking at the H.C. Wainwright 2021 Psychedelics in Psychiatry and Beyond conference. CURE Pharmaceutical Holding Corp. (OTC: CURR), a technology focused, vertically integrated drug delivery and product development company in the pharmaceutical and health & wellness markets, announced today that its Chief Business Officer…

Field Trip Health Ltd. Announces Completion of DMPK Studies, Engineering Batch for FT-104, Its Novel Psychedelic Compound

Jun 15 • 3 min read

Quick Take: Field Trip Health has completed its initial metabolism and pharmacokinteic studies of its novel psychedelic compound Field Trip Health Ltd. (TSX: FTRP), a leader in the development and delivery of psychedelic therapies, today announced that it has completed initial drug metabolism and pharmacokinetic (“DMPK”) studies for FT-104, its novel psychedelic compound in development….

Mindset and InterVivo Solutions Announce Availability of First Preclinical Psychedelic Benchmark Data from COPE Program

Jun 14 • 4 min read

Quick Take: Mindset Pharma and InterViro announced the availability of their first data set from their “COPE” program. The COPE program aims to create benchmark data for clinically relevant psychedelic drugs. Mindset Pharma Inc. (CSE: MSET), a drug discovery and development company focused on creating optimized and patentable next-generation psychedelic medicines to treat neurological and psychiatric…

PharmaTher Provides Research and Development Update and Milestones for 2021

Jun 11 • 6 min read

Quick Take: PharmaTher has announced an update on the research and development of its psychedelics product. PharmaTher Holdings Ltd. (CSE: PHRM), a clinical-stage psychedelics biotech company, is pleased to provide an update on the research and development initiatives of its psychedelic product programs and upcoming milestones for 2021. “We are well-positioned, both financially and operationally,…

Red Light Holland Closes Acquisition of 80% of Happy Caps Mushroom Farm – Specializing in Grow-At-Home Mushroom Kits

Jun 11 • 4 min read

Quick Take: Red Light Holland has closed on a deal with Happy Caps Mushroom Farm. This deal will give Red Light Holland an 80% stake in Happy Caps. Red Light Holland Corp. (CSE: TRIP), an Ontario-based corporation engaged in the production, growth and sale of a premium brand of magic truffles to the legal, recreational…

Pages: 123456789101112131415161718192021222324252627282930313233343536373839404142434445464748495051525354555657585960616263646566676869707172737475767778798081828384858687888990919293949596979899100101102103104105106107108109110111112113114115116117118119120121122123124125126127128129130131132133134135136137138139140141142143144145146147148149150151152153154155156157158159160161162163164165166167168169170171172173174175176177178179180181182183184185186187188189190191192193194195196197198199200201202203204205206207208209210211212213214215216217218219220221222223224225226227228229230231232233234235236237238239240241242243244245246247248249250251252253254255256257258259260261262263264265266267268269270271272273274275276277278279280281282283284285286287288289290291292293294295296297298299300301302303304305306307308309310311312313314315316317318319320321322323324325326327328329330331332333334335336337338339340341342343344345346347348349350351352353354355356357358359360361362363364365366367368369370371372373374375376377378379380381382383384385386387388389390391392393394395396397398399400401402403404405406407408409410411412413414415416417418419420421422423424425426427428429430431432433434435